glp-1 nausea law office in michigan GLP-1s are great, but researchers are busy looking to add options for patients. A new U-M study reveals a missing step a weight control pathway that could be targeted for obesity Severe Stomach Paralysis Linked to

Newly released clinical trial data on the GLP-1 agonist drug Wegovy found that weight loss was sustained for up to four years after participants started taking the once-weekly injected medication

Muscle cramps affect some patients taking semaglutide for weight loss

Four study groups were established: all GLP-1RA users, SGLT2i users, insulin users and other glucose-lowering agent users (miscellany group)

Can GLP-1 medications cause shortness of breath

The UK Medicines and Healthcare products Regulatory Agency (MHRA) has today approved a new indication for Wegovy (semaglutide) to reduce the risk of overweight and obese adults suffering serious heart problems or strokes.